NoeticInsight

Dr. Rachna Shroff, expert in Colorectal cancer, shares her thoughts on the use of aspirin to reduce risk of recurrence in PIK3CA mutated colorectal cancer patients. Learn what HCPs are saying about the data and how it impacts your brand strategy at https://hubs.li/Q036F9wH0 #NoeticInsight #ColorectalCancer #PIK3CA #aspirinregimen #GI25

“The NRGI fusion positive pancreas cancers, which are rare, but zenocutuzumab is a drug that targets them that has been FDA approved.” Dr. Rachna Shroff explains the most recent treatment updates for pancreatic cancer. Don't miss out on the latest developments in oncology! Learn more: https://hubs.li/Q0362bCm0 #NoeticInsight #GIASCO2025 #CongressInsights #PancreaticCancer

NoeticCongress has helped our clients pinpoint the insights they need to identify strategic opportunities and potential obstacles. This service allows you to quickly access a panel of experts and gather feedback on breaking data, clinical trial development, and desired outcomes. Contact us to get started: https://hubs.li/Q0361nyS0 #clinicaltrials #healthdata #pharma #lifesciences

“In the past year, we’ve had FDA approvals across a lot of different tumor types, [as well as] tumor agnostic approvals that are still very relevant to GI cancers.” Dr. Rachna Shroff reflects on the progress made in the GI cancer landscape in 2024. #NoeticInsight #GIASCO2025 #CongressInsights #ColorectalCancer

Our clients have found ways to obtain insights in a manner that’s faster and more personalized than ever before. See the benefit that NoeticInsight services can provide for your strategy: https://hubs.ly/Q0353tGm0 #NoeticInsight #pharma #lifesciences #physicians

The ANGELICA trial, which is treating patients in Singapore’s National University Hospital, shows immense promise in creating ready-made treatments from the cells of healthy donors. The results of the trial could be far-reaching and extend the possibility of CAR T-cell treatments to fight over 20 different types of cancer. #CARTcell #cancertreatment #cancerresearch #immunotherapy #NoeticInsight

Dr. Rena Callahan, expert in Breast Cancer, describes the promising PATINA trial findings presented at SABCS. #NoeticInsight #SABCS2024 #CongressInsights #PATINA

In the study, nearly 75% of participants experienced complete cancer remission after being treated with a novel treatment, cretostimogene grenadenorepvec. The oncolytic immunotherapy attacks cancer cells and creates an immune response against bladder cancer. The treatment has the potential to greatly improve quality of life for patients with bladder cancer. #NoeticInsight #bladdercancer #cancerresearch Source: https://lnkd.in/eZhsZ9_R

“The EMERALD trial represented the first time in over 20 years that there was a new endocrine therapy that was better than aromatase inhibitors.” Dr. Rena Callahan, expert in Breast Cancer, describes the changing treatment landscape for aromatase inhibitors. #SABCS2024

When discussing the Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic cancer- adenocarcinoma, Dr. Rachna Shroff explained that the trail shows “some interesting signals for efficacy.” #NoeticInsight #GIASCO2025 #CongressInsights #PancreaticCancer